Mayne Pharma Group Limited (MYX.AX)
AUD 4.85
(-2.02%)
AUD 4.85
(-2.02%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.3 Million | -43.12 Million | -16.61 Million | 47.25 Million | 99.77 Million | 106.6 Million |
| Net Income | -174.23 Million | -317.35 Million | -209.48 Million | -208.42 Million | -92.78 Million | -279.2 Million |
| Depreciation & Amortization | 71.62 Million | 65.44 Million | 55.18 Million | 68.18 Million | 84.56 Million | 89.38 Million |
| Deferred income taxes | -23.19 Million | 49.99 Million | 63.41 Million | -43.93 Million | -42.62 Million | -50.62 Million |
| Stock-based compensation | 4.09 Million | 6.77 Million | 4.57 Million | 7.74 Million | 6.98 Million | 9 Million |
| Change in working capital | 25.17 Million | 145.42 Million | -8.87 Million | -13.58 Million | 50.16 Million | 3 Million |
| Other non-cash items | 58.05 Million | 6.59 Million | 78.56 Million | 237.27 Million | 93.47 Million | 335.04 Million |
| Investing Cash Flow | 53.44 Million | 473.48 Million | -28.52 Million | -49.24 Million | -55.87 Million | -91.68 Million |
| Investments in PPE | -20.86 Million | -219.58 Million | -11.85 Million | -25.09 Million | -47.11 Million | -11.91 Million |
| Acquisitions | 6.85 Million | 842.21 Million | 5.16 Million | - | -8.75 Million | -9.76 Million |
| Investment purchases | - | -127.52 Million | - | - | - | -475 Thousand |
| Sales/Maturities of investments | 89.26 Million | - | - | - | - | - |
| Other Investing Activities | -34.72 Million | -21.62 Million | -21.84 Million | -24.15 Million | -8.75 Million | -79.29 Million |
| Financing Cash Flow | -19.85 Million | -431.47 Million | 37.01 Million | -28.83 Million | 4.52 Million | -15.55 Million |
| Debt repayment | -10.94 Million | -376.04 Million | -39.78 Million | -25.82 Million | -8.34 Million | -62.54 Million |
| Dividends payments | - | -45.29 Million | - | - | - | - |
| Common Stock Repurchased | -10.93 Million | -6.22 Million | - | - | - | - |
| Common Stock Issuance | - | 2.3 Million | - | - | 72 Thousand | 7.05 Million |
| Other Financing Activities | 2.03 Million | -6.22 Million | 76.8 Million | -3 Million | 12.79 Million | 39.94 Million |
| Accounts receivables | 5.91 Million | 118.7 Million | -66.12 Million | -3.2 Million | 67.51 Million | 9.43 Million |
| Accounts payables | -39.75 Million | 45.31 Million | 60.73 Million | 16.39 Million | -26.3 Million | -30.03 Million |
| Inventory | 25.59 Million | -12.12 Million | -2.41 Million | -25.92 Million | 13.07 Million | -6.43 Million |
| Other working capital | -6.33 Million | -6.47 Million | -1.06 Million | -856 Thousand | -4.12 Million | 30.03 Million |
| Cash at beginning of period | 92.61 Million | 97.08 Million | 98.35 Million | 138.19 Million | 89.4 Million | 87.31 Million |
| Cash at end of period | 110.06 Million | 101.71 Million | 97.08 Million | 98.35 Million | 138.19 Million | 89 Million |
| Capital Expenditure | -20.86 Million | -219.58 Million | -11.85 Million | -25.09 Million | -47.11 Million | -11.91 Million |
| Effect of forex changes on cash | -847 Thousand | -2.94 Million | 6.82 Million | -8.98 Million | 354 Thousand | 2.32 Million |
| Net cash flow / Change in cash | 17.45 Million | 4.63 Million | -1.27 Million | -39.84 Million | 48.79 Million | 1.69 Million |
| Free Cash Flow | -36.16 Million | -262.7 Million | -28.47 Million | 22.15 Million | 52.65 Million | 94.69 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -168.61 Million | -103.68 Million | -70.54 Million | -317.35 Million | -188.26 Million | -129.08 Million |
| Depreciation & Amortization | 68.45 Million | 34.2 Million | 35.87 Million | 65.44 Million | 36.27 Million | 29.16 Million |
| Deferred income taxes | -23.19 Million | -18.83 Million | -4.35 Million | 49.99 Million | 89.51 Million | -39.52 Million |
| Stock-based compensation | - | 1.57 Million | 2.51 Million | 6.77 Million | 1.77 Million | 5 Million |
| Change in working capital | -14.58 Million | 30.32 Million | -19.82 Million | 145.42 Million | 95.49 Million | 49.92 Million |
| Other non-cash items | 273.55 Million | 51 Million | 111.15 Million | 6.59 Million | -37.93 Million | 30.29 Million |
| Investing Cash Flow | 53.44 Million | -13.75 Million | 67.2 Million | 473.48 Million | -4.55 Million | 478.03 Million |
| Investments in PPE | -20.86 Million | -4.77 Million | -16.19 Million | -219.58 Million | -3.25 Million | -216.32 Million |
| Acquisitions | 6.85 Million | 6.85 Million | - | 842.21 Million | 135.9 Million | 706.31 Million |
| Investment purchases | - | - | - | -127.52 Million | -127.52 Million | - |
| Sales/Maturities of investments | 89.26 Million | -2.36 Million | 91.62 Million | - | - | - |
| Other Investing Activities | -21.81 Million | -8.98 Million | -8.22 Million | -21.62 Million | -9.66 Million | -11.95 Million |
| Financing Cash Flow | -25.59 Million | 351 Thousand | -23.72 Million | -431.47 Million | -94.47 Million | -336.99 Million |
| Debt repayment | -10.94 Million | -42 Thousand | -10.99 Million | -376.04 Million | -41.08 Million | -334.95 Million |
| Dividends payments | - | - | - | -45.29 Million | -45.29 Million | - |
| Common Stock Repurchased | -10.93 Million | - | -10.93 Million | -6.22 Million | -6.22 Million | - |
| Common Stock Issuance | - | - | - | 2.3 Million | 4.35 Million | - |
| Other Financing Activities | - | 351 Thousand | -7.46 Million | -6.22 Million | -6.22 Million | -19.07 Million |
| Accounts receivables | 5.91 Million | 160 Thousand | 5.75 Million | 118.7 Million | 59.57 Million | 59.12 Million |
| Accounts payables | -39.75 Million | -25.09 Million | -14.66 Million | 45.31 Million | 31.25 Million | 14.05 Million |
| Inventory | 25.59 Million | 22.42 Million | 3.16 Million | -12.12 Million | 2.13 Million | -14.26 Million |
| Other working capital | -6.33 Million | 7.73 Million | -14.07 Million | -6.47 Million | 2.52 Million | -8.99 Million |
| Cash at beginning of period | 101.71 Million | 109.22 Million | 101.71 Million | 97.08 Million | 175.54 Million | 97.08 Million |
| Cash at end of period | 112.38 Million | 112.38 Million | 109.22 Million | 101.71 Million | 101.71 Million | 175.54 Million |
| Capital Expenditure | -20.86 Million | -4.77 Million | -16.19 Million | -219.58 Million | -3.25 Million | -216.32 Million |
| Effect of forex changes on cash | - | 827 Thousand | -1.67 Million | -2.94 Million | 594 Thousand | -3.53 Million |
| Net cash flow / Change in cash | 10.67 Million | 3.16 Million | 7.51 Million | 4.63 Million | -73.82 Million | 78.46 Million |
| Free Cash Flow | -30.41 Million | 8.64 Million | -41.38 Million | -262.7 Million | 12.24 Million | -274.95 Million |
7106
ME8U
GIFLF
DVHGF
3379
A1M